** Shares of Monte Rosa Therapeutics GLUE.O jump 35.6% to $6.52
** Stock set for its biggest one-day pct. gain in over 10 months, if gains hold
** Company says it has entered into an agreement to collaborate with Swiss drugmaker Novartis NOVN.S to develop drugs for immune-mediated diseases
** The deal includes an upfront payment of $120 million to Monte Rosa, with the company eligible for a total of up to $5.7 billion in milestones and option payments across programs
** Wedbush analyst Robert Driscoll says the deal represents additional validation of Monte Rosa's molecular glue degrader discovery platform from an existing large‑pharma partner
** U.S.-listed shares of Novartis down 1% at $122.81
** Including session move, GLUE down 6.6%, NVS up 26% YTD